CARs are engineered proteins incorporating intracellular motifs from signaling molecules such as CD3ζ and CD28, alongside regions for antigen recognition (generally a single-chain variable fragment, scFv, generally from antibodies against tumor-associated or -specific antigens) (Figure 3). Here, CD28 is linked to neoplasm.